A novel goldĲI) complex based on an aminotriazole N-heterocylic carbene ligand represents a promising scaffold for the design of anticancer bioorganometallics. The complex triggered cytotoxic effects in HT-29 and MDA-MB-231 cancer cells, inhibited the activity of the enzyme thioredoxin reductase and showed an effective and fast cellular accumulation.
According to the literature, 1f,9 azolium salts containing weakly coordinating counterions such as PF 6 − , BF 4 − , or ClO 4 − often do not react directly with Ag 2 O and the presence of an additional base such as NaOH is required. Some reports claim that a source of halide (for instance, trialkylammonium chloride) is also necessary for the reaction to proceed. 1f,9 Due to this fact, a modification of the method by Wang and Lin has been recently proposed by Monkowius et al. allowing the smooth generation of AgĲNHC) 2 Y (Y = PF 6 , SF 6 , or ClO 4 ) from the corresponding imidazolium salt, using AgCl and an excess of KOH. 9b Referring to the established equilibrium between (NHC)AgX and ĳAgĲNHC) 2 ]AgX 2 in solution, the authors argued that AgCl was required as a source of chloride ion and postulated the formation of the (NHC)AgCl species as intermediates. Later, this procedure has been also applied for the synthesis of two homoleptic silverĲI) carbene complexes derived from 1,2,4-triazolium perchlorate salts. NMR spectra of the complexes (see Fig. S1 -S4 in the ESI †). Particularly, the 1 H NMR spectra of 2 and 3 lack the signal of the C(5)H proton that is observed at 9.74 ppm in the spectrum of the triazolium salt 1. 7 The formation of the metalcarbon bond also leads to a significant (up to 38 ppm) downfield shift of C (5) Complexes 2 and 3 exhibit almost identical mid-IR spectra indicating their similar structures. For instance, the spectra of both complexes display intensive broad bands at ca. 1100 and 620 cm −1 assigned to ν as ĲClO 4 ) stretching and δĲClO 4 ) deformation vibrations, respectively, of the uncoordinated perchlorate ion. 12 Thermal stability of 3 was additionally studied by TG/DSC analysis. The complex was found to be stable up to 220-230°C, its melting at 228-229°C being followed by a two-step endothermal decomposition at 250-270°C. The molecular and crystal structure of 3 was additionally confirmed by single crystal X-ray study, however only with low resolution (see Fig. S5 and Tables S1-S3 †). Many goldĲI)-based NHC complexes, both neutral and cationic, are known as effective tumor cell growth inhibitory and pro-apoptotic agents that are able to trigger cell death via inhibition of the enzyme thioredoxin reductase (TrxR), induce reactive oxygen species formation, and cause antimitochondrial activities and other antitumoral effects. 1a,2a-d,g,h,k In order to evaluate the key biological properties of the aminotriazole NHC complex 3, we determined its antiproliferative effects in two selected cancer cell lines (namely, HT-29 colon carcinoma and MDA-MB-231 breast adenocarcinoma) and its effectivity as an inhibitor of TrxR.
Complex 3 demonstrated good cytotoxic effects in both cell lines with IC 50 values in the low micromolar range (2.1 ± 0.0 μM in the HT-29 and 1.0 ± 0.0 μM in the MDA-MB-231 cells). This is in good agreement with previous studies using imidazole and benzimidazole-based cationic ĳAuĲNHC) 2 ] + complexes in the same assay, which afforded IC 50 values in a comparable range. 13 The precursor triazolium perchlorate 1 was used as a negative control and, as expected, showed no antiproliferative activity in concentrations up to 100 μM. Complex 3 also showed moderate TrxR inhibition activity with an IC 50 value of 1.2 ± 0.6 μM as measured in the DTNB reduction assay, again comparable with the other ĳAu-ĲNHC) 2 ] + complexes. 13 Importantly, TrxR is considered to be one of the most important biological targets of Au I -based drugs. 2a,c,d,13a,14 Cellular gold uptake was assessed using high resolution continuum source atomic absorption spectroscopy (HR CS AAS) and measured in the HT-29 cells exposed to 2.0 μM (approx. IC 50 value) or 10 μM of 3 for a period of 1, 4 or 8 h. The results of the experiment are given in Fig. 1 According to the results, complex 3 led to very high cellular gold levels of up to 450 μM upon incubation with 10 μM, corresponding to an approximately 45-fold cellular accumulation with respect to the extracellular medium. Since levels after 1 and 4 hours were comparable, it can be concluded that the complex was quickly taken up by the cells. This was followed by decreased cellular gold levels after 8 h, and this effect was ‡ Synthesis of bisĲ1-tert-butyl-4-Ĳtert-butylamino)-1,2,4-triazol-5-ylidene)silverĲI) perchlorate (2); 0.50 mmol (116 mg) of Ag 2 O, 1.0 mmol (296 mg) of 1 and 2 mmol (138 mg) of anhydrous K 2 CO 3 were suspended in 20 mL of dry CH 2 Cl 2 . The suspension was stirred under nitrogen atmosphere at RT for 48 h. Then unreacted Ag 2 O was filtered off, and the filtrate was evaporated to dryness. The off-white crystalline residue of 2 was kept in the dark. Yield: 266 mg (88% in particular highly pronounced with the concentration close to the IC 50 value of cytotoxicity (2.0 μM). In general, the values are within the same order of magnitude as observed recently with a cationic biscarbene NHC complex, which had reached cellular gold levels (in the MCF-7 breast adenocarcinoma cells) in the range of 1.0-1.5 nmol mg −1 at an exposure concentration of 3.0 μM. 13a However, in these previous experiments, stable gold levels were observed.
Conclusions
Complex 3 was synthesized via the silverĲI) oxide route and was fully characterized using spectroscopic and structural methods. According to the results of the biological evaluation, it showed marked antiproliferative activity against HT-29 and MDA-MB-231 tumor cell lines with IC 50 values in the low micromolar range (1-2 μM) and good to moderate activity as inhibitor of TrxR. Cellular uptake studies showed a fast and efficient accumulation in HT-29 cells that was followed by decreased gold concentrations after 8 h. This pattern could be attributed to the fast uptake related to the cationic charge and lipophilic nature of 3 and a subsequent excretion of gold, which might be the consequence of active transport processes or metabolism. Of note, the enhanced excretion of gold is less evident at higher concentration above the IC 50 value of cytotoxicity (10 μM) when cell homeostasis is strongly affected by the toxic effects. The aminotriazole moiety of 3 is of particular interest since it displays certain possible advantages for metallodrug development. First, with its N-amino group it represents a comparably hydrophilic NHC core that could be used in the design of novel bioactive gold bioorganometallics and might overcome common solubility issues. Secondly, it could also be speculated that this NH group next to the NHC might facilitate additional interactions with the molecular targets of the complex. And thirdly, in comparison with the much more frequently studied imidazole-based carbenes, NHC ligands based on other heterocycles, particularly 1,2,4-triazole derivatives, may show altered electronic properties and donor ability. 16 Concerning the structure-activity relationships, the following conclusions can be drawn: 1) the expected impact of the gold center was clearly established as 3 was active against tumor cell growth in contrast to the metal free 1, and 2) the mode of drug action of 3 is likely dominated by the combination of the gold-based inhibition of TrxR and the antimitochondrial effects related to the cationic nature of the compound, as it has also been observed with other complexes of this general type. 1a,2b,g,13a 
